Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
8.32
+0.05 (0.60%)
At close: Feb 5, 2026, 4:00 PM EST
8.93
+0.61 (7.33%)
Pre-market: Feb 6, 2026, 8:21 AM EST
Ginkgo Bioworks Holdings Market Cap
Ginkgo Bioworks Holdings has a market cap or net worth of $472.88 million as of February 6, 2026. Its market cap has decreased by -30.94% in one year.
Market Cap
472.88M
Enterprise Value
433.89M
1-Year Change
-30.94%
Ranking
Category
Stock Price
$8.32
Market Cap Chart
Since April 19, 2021, Ginkgo Bioworks Holdings's market cap has decreased from $2.18B to $472.88M, a decrease of -78.33%. That is a compound annual growth rate of -27.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 472.88M | 0.12% |
| Dec 31, 2025 | 472.31M | -9.39% |
| Dec 31, 2024 | 521.27M | -84.36% |
| Dec 29, 2023 | 3.33B | 16.75% |
| Dec 30, 2022 | 2.86B | -76.89% |
| Dec 31, 2021 | 12.35B | 466.18% |
| Apr 19, 2021 | 2.18B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lexicon Pharmaceuticals | 503.96M |
| Lexeo Therapeutics | 502.88M |
| Tenax Therapeutics | 501.45M |
| Vor Biopharma | 501.14M |
| Solid Biosciences | 485.38M |
| Verastem | 484.70M |
| ADC Therapeutics | 484.36M |
| Invivyd | 482.20M |